BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36401730)

  • 61. Second primary osteosarcomas in patients with retinoblastoma.
    Fujiwara T; Fujiwara M; Numoto K; Ogura K; Yoshida A; Yonemoto T; Suzuki S; Kawai A
    Jpn J Clin Oncol; 2015 Dec; 45(12):1139-45. PubMed ID: 26438540
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Osteosarcoma as a second malignant neoplasm in children.
    Bechler JR; Robertson WW; Meadows AT; Womer RB
    J Bone Joint Surg Am; 1992 Aug; 74(7):1079-83. PubMed ID: 1522094
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
    Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
    Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma.
    Fitzhugh CD; Wise B; Baird K; Tsokos M; Helman L; Mackall C; Savage SA; Warren KE
    Pediatr Blood Cancer; 2009 Sep; 53(3):496-8. PubMed ID: 19434734
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
    Smeland S; Bielack SS; Whelan J; Bernstein M; Hogendoorn P; Krailo MD; Gorlick R; Janeway KA; Ingleby FC; Anninga J; Antal I; Arndt C; Brown KLB; Butterfass-Bahloul T; Calaminus G; Capra M; Dhooge C; Eriksson M; Flanagan AM; Friedel G; Gebhardt MC; Gelderblom H; Goldsby R; Grier HE; Grimer R; Hawkins DS; Hecker-Nolting S; Sundby Hall K; Isakoff MS; Jovic G; Kühne T; Kager L; von Kalle T; Kabickova E; Lang S; Lau CC; Leavey PJ; Lessnick SL; Mascarenhas L; Mayer-Steinacker R; Meyers PA; Nagarajan R; Randall RL; Reichardt P; Renard M; Rechnitzer C; Schwartz CL; Strauss S; Teot L; Timmermann B; Sydes MR; Marina N
    Eur J Cancer; 2019 Mar; 109():36-50. PubMed ID: 30685685
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Metachronous skeletal osteosarcoma in patients treated with adjuvant and neoadjuvant chemotherapy for nonmetastatic osteosarcoma.
    Aung L; Gorlick R; Healey JH; Shi W; Thaler HT; Shorter NA; Huvos AG; Meyers PA
    J Clin Oncol; 2003 Jan; 21(2):342-8. PubMed ID: 12525528
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of primary osteosarcoma of flat bones with secondary osteosarcoma of any site.
    Pratt CB; Meyer WH; Rao BN; Pappo AS; Fleming ID; Luo X; Cain A; Kaste SC; Shearer PD; Jenkins JJ
    Cancer; 1997 Sep; 80(6):1171-7. PubMed ID: 9305720
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regional chemotherapy with the use of cisplatin and doxorubicin as primary treatment for advanced sarcomas in shoulder, pelvis, and thigh.
    Stephens FO; Tattersall MH; Marsden W; Waugh RC; Green D; McCarthy SW
    Cancer; 1987 Aug; 60(4):724-35. PubMed ID: 3474053
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Late effects surveillance system after childhood cancer in Germany, austria and parts of Switzerland--update 2009.
    Peeters J; Meitert J; Paulides M; Beck JD; Langer T
    Strahlenther Onkol; 2009 Aug; 185 Suppl 2():5-7. PubMed ID: 19685025
    [No Abstract]   [Full Text] [Related]  

  • 72. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
    Cassano WF; Graham-Pole J; Dickson N
    Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Rocca M; Ferrari S; Donati D; Longhi A; Bertoni F; Bacchini P; Giacomini S; Forni C; Manfrini M; Galletti S
    Ann Oncol; 2003 Jul; 14(7):1126-34. PubMed ID: 12853357
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.
    Meazza C; Luksch R; Daolio P; Podda M; Luzzati A; Gronchi A; Parafioriti A; Gandola L; Collini P; Ferrari A; Casanova M; Terenziani M; Spreafico F; Polastri D; Biassoni V; Schiavello E; Pecori E; Massimino M
    Med Oncol; 2014 Apr; 31(4):875. PubMed ID: 24557586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mucoepidermoid carcinoma as a secondary malignancy in pediatric sarcoma.
    Rutigliano DN; Meyers P; Ghossein RA; Carlson DL; Kayton ML; Kraus D; La Quaglia MP
    J Pediatr Surg; 2007 Jul; 42(7):E9-13. PubMed ID: 17618873
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
    Patel SR; Papadopolous N; Raymond AK; Donato M; Seong CM; Yasko AW; Lewis VO; Lin PP; Champlin R; Benjamin RS
    Cancer; 2004 Jul; 101(1):156-63. PubMed ID: 15222001
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adjuvant chemotherapy for osteogenic sarcoma of the extremity with sequential adriamycin and cisplatin.
    Pathak AB; Advani SH; Iyer RS; Pai SK; Gopal R; Nadkarni KS; Saikia TK; Kurkure PA; Nair CN; Pai VR
    J Surg Oncol; 1993 Mar; 52(3):181-4. PubMed ID: 8441277
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
    Wei L; Song XR; Wang XW; Li M; Z uo WS
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Local radiotherapy combined with systemic chemotherapy in 3 children with osteosarcoma of an extremity].
    Kühl J; Richter E; Wünsch PH; Höcht B; Kühner U; Bohndorf W
    Klin Padiatr; 1986; 198(3):267-70. PubMed ID: 3459936
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.